MedPath

湖南先施制药有限公司

Ownership
-
Established
2021-05-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Vonoprazan Fumarate Tablets

Product Name
富马酸伏诺拉生片
Approval Number
国药准字H20254464
Approval Date
Jun 3, 2025
NMPA

Vonoprazan Fumarate Tablets

Product Name
富马酸伏诺拉生片
Approval Number
国药准字H20254463
Approval Date
Jun 3, 2025
NMPA

Nimodipine Oral Solution

Product Name
尼莫地平口服溶液
Approval Number
国药准字H20254009
Approval Date
Apr 30, 2025
NMPA

Nimodipine Oral Solution

Product Name
尼莫地平口服溶液
Approval Number
国药准字H20254010
Approval Date
Apr 30, 2025
NMPA

Loxoprofen Sodium Oral Solution

Product Name
洛索洛芬钠口服溶液
Approval Number
国药准字H20253798
Approval Date
Apr 1, 2025
NMPA

Thioctic Acid Tablets

Product Name
硫辛酸片
Approval Number
国药准字H20253712
Approval Date
Mar 25, 2025
NMPA

Thioctic Acid Tablets

Product Name
硫辛酸片
Approval Number
国药准字H20253713
Approval Date
Mar 25, 2025
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20253332
Approval Date
Feb 8, 2025
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20253333
Approval Date
Feb 8, 2025
NMPA

Phloroglucinol Orally Disintegrating Tablets

Product Name
间苯三酚口崩片
Approval Number
国药准字H20249511
Approval Date
Dec 1, 2024
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.